retifanlimab
ItalyDrugs containing this active substance
-
It is used in adults to treat squamous cell carcinoma of the anal canal (when the tumor has spread or recurred and is inoperable) and Merkel cell carcinoma (a rare skin tumor that cannot be treated with surgery or radiotherapy).
Form: solution for infusion, concentrate
Active substance Dosage retifanlimab - ATC: L01FF10
Manufacturer: INCYTE BIOSCIENCES DISTRIBUTION B.V.